Nurse Practitioner, Family · Garden City, NY
NPI
1881185973
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
711 Stewart Ave
Garden City, NY, 11530
Phone (516) 321-3434
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
509 services
Medicare patients, 2024
132
Average age 73
Drug cost, 2024
$453K
795 prescriptions
Company payments, 2025
$947
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharon Hochhauser was code 17003 (destruction skin lesion), 150 times for 29 patients. In total Sharon Hochhauser billed 509 services in 35 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 150 | 29 | $5.18 | $776 |
| 99214 Office E&M - Established | Office | 64 | 51 | $87.85 | $5,623 |
| 17110 Destruction Skin Lesion | Office | 47 | 40 | $77.92 | $3,662 |
| 17000 Destruction Skin Lesion | Office | 42 | 33 | $39.06 | $1,641 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 32 | 14 | $0.77 | $24.49 |
| 99213 Office E&M - Established | Office | 25 | 25 | $65.84 | $1,646 |
| 99204 Office E&M - New | Office | 19 | 19 | $127.13 | $2,415 |
| 17004 Destruction Skin Lesion | Office | 15 | 11 | $122.85 | $1,843 |
| 11102 Skin Biopsy | Office | 11 | 11 | $57.21 | $629 |
By year: 2022 $9,287 for 205 services; 2023 $16K for 428 services; 2024 $25K for 509 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharon Hochhauser prescribed most often to Medicare patients was Triamcinolone Acetonide, with 139 prescriptions and refills. In total Sharon Hochhauser wrote 795 Medicare prescriptions that cost $453K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 139 | 145 | 91 | $2,416 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 128 | 131 | 65 | $9,950 |
| Ketoconazole Generic | 83 | 84 | 36 | $1,540 |
| Clobetasol Propionate Generic | 74 | 78 | 29 | $4,596 |
| Opzelura Ruxolitinib Phosphate | 56 | 56 | 20 | $174K |
| Ammonium Lactate Generic | 49 | 49 | 25 | $1,288 |
| Tretinoin Generic | 30 | 30 | 12 | $2,776 |
| Mupirocin Generic | 26 | 26 | 18 | $159 |
| Clindamycin Phosphate Generic | 23 | 25 | Under 11 | $848 |
| Vtama Tapinarof | 20 | 20 | Under 11 | $29K |
| Calcipotriene Generic | 17 | 17 | Under 11 | $4,010 |
| Halobetasol Propionate Generic | 15 | 16 | Under 11 | $901 |
| Fluocinonide Generic | 14 | 14 | Under 11 | $791 |
| Otezla Apremilast | 13 | 13 | Under 11 | $64K |
| Hydrocortisone Generic | 13 | 13 | Under 11 | $52.98 |
Brand drugs: 146 claims; generic drugs: 649 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon Hochhauser $947 ($947 in general payments such as food, travel and fees) from 13 companies. The largest payer was Incyte Corporation with $255.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 16 | $255 |
| Abbvie Inc. ABBV | 11 | $194 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $74.1 |
| Organon LLC OGN | 5 | $69.94 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $59.39 |
| Janssen Biotech, Inc. JNJ | 2 | $46.77 |
| UCB, Inc. UCB.BR | 2 | $38.95 |
| Pfizer Inc. PFE | 2 | $37.7 |
| Lilly USA, LLC LLY | 2 | $34.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.